Archive Projects

Projects

Projects Search Results

AGC Biologics to Invest 50 Billion Japanese yen for New Manufacturing Plant in Yokohama, Japan

AGC Biologics

Yokohama, Japan

Project Cost : 50 Billion Japanese yen

Axplora Invests €8 Million to Expand Antibody Drug Conjugate Manufacturing in Le Mans,France

Axplora

Le Mans,France

Project Cost : €8 Million

Adare Pharma Solutions Plans for expansion of Packaging & Warehousing Capabilities in Milan, Italy.

Adare Pharma Solutions

Milan

Project Cost : -

AstraZeneca to Invest ₹250 Crore to Expand Global Innovation and Technology Centre in Tamil Nadu,India

AstraZeneca

Tamil Nadu,India

Project Cost : ₹250 Crore

Novo Nordisk to invest $4.1 billion to Expand Manufacturing Facility in North Carolina,USA

Novo Nordisk

North Carolina,USA

Project Cost : $4.1 billion

Gerresheimer to Invest $180 million to Expand Medical Systems Capacity in USA.

Gerresheimer

USA

Project Cost : $180 million

AbbVie to Invest $223 Million to Expand Biologics Manufacturing Capacity in Singapore.

AbbVie

Singapore

Project Cost : $223 Million

Piramal Pharma Solutions to Invest $80 Million to Expand Sterile Injectables Plant in Kentucky, USA.

Piramal Pharma Solutions

Kentucky,USA

Project Cost : $80 Million

Nucleus RadioPharma Expands Radiopharmaceutical R&D and Production Capacity in USA

Nucleus RadioPharma

USA

Project Cost : -

GSK to Invest $800 Million to Drug Manufacturing Capabilities at Pennsylvania Site in USA

GSK

Pennsylvania, USA

Project Cost : $800 Million

Johnson & Johnson to Invest $2 billion in Advanced Biologics manufacturing Plant in North Carolina, USA

Johnson & Johnson

North Carolina, USA

Project Cost : $2 billion

Lilly plans to expand $3 billion of acquired manufacturing facility in Wisconsin

Eli Lilly and Company

Wisconsin

Project Cost : $3 billion

Novo Nordisk to Invest DKK 8.5 Billion to New Manufacturing Plant in Odense, Denmark

Novo Nordisk

Odense, Denmark

Project Cost : DKK 8.5 Billion

AstraZeneca Invests $1.5 Billion to Construct Antibody Drug Conjugate Facility in Singapore

AstraZeneca

Singapore

Project Cost : $1.5 Billion

CordenPharma to Invest €500 Million for Construction of New Greenfield Peptide Facility in Basel, Switzerland

CordenPharma

Switzerland

Project Cost : €500M